Has Grant Gaines received payments from drug or device companies?

Yes. Drug and device makers reported $1,135 in general payments to Grant Gaines across 61 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Grant Gaines did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Grant Gaines come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Grant Gaines

Pediatrics · Fayetteville, ARNPI 1154784320

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Corium, LLC at 28.6% of the total. 2025 is the largest year on record at $277, more than ten times the $14 reported in 2019.

$1,135in general payments, 2019–2025

Across 61 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corium, LLC$325
Pfizer$229
Genentech USA, Inc.$150
Merck$86
Supernus Pharmaceuticals, Inc.$80
AstraZeneca$54
plus $211 from 8 others

$567,754in research payments, 2019–2025

Across 10 payments — averaging $56,775 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$568K

What the payments were for

Food & beverage$1,135100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corium, LLC	17	$325
Pfizer	13	$229
Genentech USA, Inc.	3	$150
Merck	6	$86
Supernus Pharmaceuticals, Inc.	5	$80
AstraZeneca	4	$54
Sanofi Pasteur Inc.	3	$51
GSK	3	$45
Sobi, Inc	2	$30
Avion Pharmaceuticals	1	$22
Collegium Pharmaceutical, Inc.	1	$18
Sanofi-aventis U.S. LLC	1	$17
Boston Scientific	1	$15
Takeda Pharmaceuticals U.S.A., Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Xofluza$125

How this compares

$1,135 in reported general payments places this provider in the 85th percentile of 464 pediatrics providers in Arkansas.

See all pediatrics providers in Arkansas →

Other pediatrics in Fayetteville

John SimmonsFayetteville$3K
Terry PaytonFayetteville$2K
Brentley SilveyFayetteville$2K
Joe RobinsonFayetteville$2K
Sean LivingstonFayetteville$2K
Whitney AlexanderFayetteville$1K
Elizabeth FerebeeFayetteville$1K
Daniel RasmussenFayetteville$1K
Virginia ThomasFayetteville$1K
James SwindleFayetteville$1K

See the full list for Arkansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →